Hypertrophic cardiomyopathy (HCM) is a common potentially deadly disease in cats. Early diagnosis and staging are critical to treatment. Cats with HCM are at risk of developing clots in their hearts. These clots can travel elsewhere in the body, significantly worsening prognosis in affected cats. The standard treatment to help prevent clots is clopidogrel (Plavix). Unfortunately, some cats appear resistant to this life-saving medication.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to CatWatch
Get the next year of CatWatch for just $20. And access all of our back issues and online content free of charge.
Subscribe today and save 50% off the regular rate!
